Variable | Local control | Overall survival | ||||
---|---|---|---|---|---|---|
HR | 95% CI | p | HR | 95% CI | p | |
CTP | 1.725 | (0.406–7.335) | 0.5 | 1.806 | (0.884–3.691) | 0.1 |
Multifocality | 0.696 | (0.085–5.688) | 0.7 | 1.471 | (0.512–4.228) | 0.5 |
Diameter | 1.147 | (1.008–1.305) | 0.04 | 1.017 | (0.952–1.086) | 0.6 |
Extrahepatic disease | n.a. |  |  | 0.653 | (0.260–1.640) | 0.7 |
Fractionation | 0.919 | (0.755–1.118) | 0.4 | 0.952 | (0.860–1.053) | 0.3 |
SIP | 0.950 | (0.227–3.989) | 0.9 | 1.298 | (0.639–2.637) | 0.5 |
GTV Volume | 1.001 | (1.000–1.002) | 0.008 | 1.001 | (1.000–1.001) | 0.008 |
TVT | 0.977 | (0.189–5.058) | 0.9 | 1.674 | (0.781–3.590) | 0.2 |
EQD210, prescribed | 0.952 | (0.907–0.998) | 0.04 | 1.002 | (0.978–1.026) | 0.9 |
EQD210, Dmax | 0.992 | (0.967–1.017) | 0.5 | 0.998 | (0.988–1.008) | 0.7 |
EQD210, D95% | 0.978 | (0.919–1.014) | 0.4 | 1.013 | (0.990–1.036) | 0.3 |
EQD22, mean liver dose | n.a. |  |  | 1.009 | (0.967–1.054) | 0.6 |
BCLC | n.a. |  |  | 0.868 | (0.428–1.761) | 0.7 |